Pregnane progestin contraception in systemic lupus erythematosus: A longitudinal study of 187 patients

Contraception

Volumn 83, Issue 3, 2011, Pages 229-237

  Chabbert Buffet, Nathalie ^a,b   Amoura, Zahir ^b   Scarabin, Pierre Yves ^c   Frances, Camille ^b   Lévy, Delphine P ^a   Galicier, Lionel ^a   Wechsler, Bertrand ^b   Blétry, Olivier ^d   Piette, Jean Charles ^b   Gompel, Anne ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c INSERM   (France)

^d FOCH HOSPITAL   (France)

Author keywords

Arterial thrombosis; Bleeding; Low dose progestin only contraception; Systemic lupus erythematosus; Venous thrombosis

Indexed keywords

CHLORMADINONE ACETATE; CYPROTERONE ACETATE;

ADULT; AGED; ARTERY OCCLUSION; ARTICLE; BREAKTHROUGH BLEEDING; CONTRACEPTION; DEEP VEIN THROMBOSIS; DISEASE ACTIVITY; DRUG TOLERABILITY; FEMALE; HEART INFARCTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MICROTHROMBUS; PREGNANCY; SAFETY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; ANDROGEN ANTAGONISTS; ANTIBODIES, ANTIPHOSPHOLIPID; CHI-SQUARE DISTRIBUTION; CHLORMADINONE ACETATE; COHORT STUDIES; CONTRACEPTION; CYPROTERONE ACETATE; FEMALE; HUMANS; LONGITUDINAL STUDIES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; PROSPECTIVE STUDIES; VENOUS THROMBOSIS; YOUNG ADULT;

EID: 79951512461     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2010.08.012     Document Type: Article

References (58)

1. Gimovsky M.L., Montoro M., and Paul R.H. Pregnancy outcome in women with systemic lupus erythematosus Obstet Gynecol 63 1984 686 692 (Pubitemid 14143925)
2. Gompel A., and Bletry O. Contraception and pregnancy in systemic lupus erythematosus Rev Prat 40 1990 1946 1951
3. Culwell K.R., Curtis K.M., and del Carmen Cravioto M. Safety of contraceptive method use among women with systemic lupus erythematosus: a systematic review Obstet Gynecol 114 2009 341 353
4. Petri M. Hopkins Lupus Pregnancy Center: 1987 to 1996 Rheum Dis Clin North Am 23 1997 1 13 (Pubitemid 27089252)
5. Costenbader K.H., Brome D., Blanch D., Gall V., Karlson E., and Liang M.H. Factors determining participation in prevention trials among systemic lupus erythematosus patients: a qualitative study Arthritis Rheum 57 2007 49 55
6. Whitelaw D.A., and Jessop S.J. Major flares in women with SLE on combined oral contraception Clin Rheumatol 26 2007 2163 2165 (Pubitemid 350120361)
7. Glueck H.I., Kant K.S., Weiss M.A., Pollak V.E., Miller M.A., and Coots M. Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants Arch Intern Med 145 1985 1389 1395 (Pubitemid 15049790)
8. Petri M., Rheinschmidt M., Whiting-O'Keefe Q., Hellmann D., and Corash L. The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level Ann Intern Med 106 1987 524 531 (Pubitemid 17095036)
9. Jick H., Jick S.S., Gurewich V., Myers M.W., and Vasilakis C. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components Lancet 346 1995 1589 1593 (Pubitemid 26001840)
10. Spitzer W.O., Lewis M.A., Heinemann L.A., Thorogood M., and MacRae K.D. Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women BMJ 312 1996 83 88
11. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception Venous thromboembolic disease and combined oral contraceptives: results of an international multicenter case-control study Lancet 346 1995 1575 1582
12. Petri M., Kim M.Y.K.K., and Grossman J. OC-SELENA Trial. Combined oral contraceptives in women with systemic lupus erythematosus N Engl J Med 353 2005 2550 2558 (Pubitemid 41785892)
13. Sanchez-Guerrero J., Uribe A.G.J.S.L., Mestanza-Peralta M., Lara-Reyes P.S.A., and Cravioto M.D. A trial of contraceptive methods in women with systemic lupus erythematosus N Engl J Med 353 2005 2539 2549 (Pubitemid 41785891)
14. Julkunen H.A., Kaaja R., and Friman C. Contraceptive practice in women with systemic lupus erythematosus Br J Rheumatol 32 1993 227 230 (Pubitemid 23089987)
15. Poulter N.R., Chang C.L., Farley T.M., and Meirik O. Risk of cardiovascular diseases associated with oral progestagen preparations with therapeutic indications Lancet 354 1999 1610 (Pubitemid 29515956)
16. Vasilakis C., Jick H., and M. del Mar Melero-Montes Risk of idiopathic venous thromboembolism in users of progestagens alone Lancet 354 1999 1610 1611 (Pubitemid 29515957)
17. Burkman R.T. Intrauterine device use and the risk of pelvic inflammatory disease Am J Obstet Gynecol 138 1980 861 863 (Pubitemid 11198955)
18. Prager S., and Darney P.D. The levonorgestrel intrauterine system in nulliparous women Contraception 75 2007 S12 S15
19. Kuttenn F., Rigaud C., Wright F., and Mauvais-Jarvis P. Treatment of hirsutism by oral cyproterone acetate and percutaneous estradiol J Clin Endocrinol Metab 51 1980 1107 1111 (Pubitemid 11225471)
20. Pelissier C., Basdevant A., Conard J., Egloff M., Husson T., and Guyenne T.T. Progestogen contraception using chlormadinone acetate in women presenting high vascular risk. A gynecoendocrine, metabolic and vascular study Contracept Fertil Sex (Paris) 15 1987 45 54 (Pubitemid 17020056)
21. Gompel A. Contraceptions in women with contra-indication to estrogen-progestins Rev Prat 45 1995 2431 2434
22. Tan E.M., Cohen A.S., and Fries J.F. The 1982 revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum 25 1982 1271 1277 (Pubitemid 13221242)
23. Huong D.L., Papo T., and Beaufils H. Renal involvement in systemic lupus erythematosus. A study of 180 patients from a single center Medicine (Baltimore) 78 1999 148 166 (Pubitemid 29231142)
24. Jungers P., Kuttenn F., and Liote F. Hormonal modulation in systemic lupus erythematosus. Preliminary clinical and hormonal results with cyproterone acetate Arthritis Rheum 28 1985 1243 1250 (Pubitemid 16214076)
25. Lunell N.O., Zador G., Carlstrom K., Eneroth P., Patek E., and Wager J. The effect of cyproterone acetate on pituitary-ovarian function and clinical symptoms in hirsute women Acta Endocrinol (Copenh) 100 1982 91 97 (Pubitemid 12150490)
26. Wolff J.P., Cachelou R., and Gueritee N. Absence of systemic hormonal effects in an oestradiol diether topically active on the vaginal mucosa Maturitas 4 1982 239 246 (Pubitemid 13189092)
27. Bombardier C., Gladman D.D., Urowitz M.B., Caron D., and Chang C.H. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE Arthritis Rheum 35 1992 630 640
28. Churg J.B.J., and Glassock R.J. Lupus nephritis Churg Renal diseases: classification and atlas of glomerular diseases 1995 Igaku-Shoin New York 151 180
29. Schindler A.E., Campagnoli C., and Druckmann R. Classification and pharmacology of progestins Maturitas 46 Suppl 1 2003 S7 S16
30. Sullivan J.M., and Lobo R.A. Considerations for contraception in women with cardiovascular disorders Am J Obstet Gynecol 168 1993 2006 2011 (Pubitemid 23187962)
31. Baird D.T., and Glasier A.F. Hormonal contraception N Engl J Med 328 1993 1543 1549
32. A double-blind study comparing the contraceptive efficacy, acceptability and safety of two progestogen-only pills containing desogestrel 75 micrograms/day or levonorgestrel 30 micrograms/day. Collaborative Study Group on the Desogestrel-Containing Progestogen-Only Pill Eur J Contracept Reprod Health Care 3 1998 169 178
33. Conard J., Plu-Bureau G., Bahi N., Horellou M.H., Pelissier C., and Thalabard J.C. Progestogen-only contraception in women at high risk of venous thromboembolism Contraception 70 2004 437 441 (Pubitemid 39488199)
34. Frederiksen M.C. Depot medroxyprogesterone acetate contraception in women with medical problems J Reprod Med 41 1996 414 418 (Pubitemid 26172583)
35. Chakhtoura Z., Canonico M., Gompel A., Thalabard J.C., Scarabin P.Y., and Plu-Bureau G. Progestogen-only contraceptives and the risk of stroke: a meta-analysis Stroke 40 2009 1059 1062
36. Cretel E., Cacoub P., Huong D.L., Gompel A., Amoura Z., and Piette J.C. Massive ovarian haemorrhage complicating oral anticoagulation in the antiphospholipid syndrome: a report of three cases Lupus 8 1999 482 485 (Pubitemid 29423586)
37. Lakasing L., and Khamashta M. Contraceptive practices in women with systemic lupus erythematosus and/or antiphospholipid syndrome: what advice should we be giving? J Fam Plann Reprod Health Care 27 2001 7 12
38. Collaborative Study Group on the Desogestrel-Containing Progestogen-Only Pill A double-blind study comparing the contraceptive efficacy, acceptability and safety of two progestogen-only pills containing desogestrel 75 micrograms/day or levonorgestrel 30 micrograms/day Eur J Contracept Reprod Health Care 3 1998 169 178
39. Hidalgo M.M.L.C., Juliato C.T., Espejo-Arce X., Monteiro I., and Bahamondes L. Ovarian cysts in users of Implanon and Jadelle subdermal contraceptive implants Contraception 73 2006 532 536
40. Fruzzetti F., Genazzani A.R., Ricci C., De Negri F., Bersi C., and Carmassi F. A 12-month clinical investigation with a 24-day regimen containing 15 microg ethinylestradiol plus 60 microg gestodene with respect to hemostasis and cycle control Contraception 63 2001 303 307 (Pubitemid 32970786)
41. Jondet M., and Dehennin L. Impact of different progestins on endometrial vascularisation of postmenopausal women. A retrospective image analysis-morphometric study Maturitas 46 2003 165 171 (Pubitemid 37338405)
42. Bhattoa H.P., Bettembuk P., Balogh A., Szegedi G., and Kiss E. Bone mineral density in women with systemic lupus erythematosus Clin Rheumatol 21 2002 135 141 (Pubitemid 34649595)
43. Wahl D.G., Guillemin F., de Maistre E., Perret C., Lecompte T., and Thibaut G. Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus - a meta-analysis Lupus 6 1997 467 473 (Pubitemid 27395386)
44. Seaman H.E., de Vries C.S., and Farmer R.D. The risk of venous thromboembolism in women prescribed cyproterone acetate in combination with ethinyl estradiol: a nested cohort analysis and case-control study Hum Reprod 18 2003 522 526 (Pubitemid 36329318)
45. Vasilakis-Scaramozza C., and Jick H. Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives Lancet 358 2001 1427 1429 (Pubitemid 33055749)
46. Spitzer W.O. Cyproterone acetate with ethinylestradiol as a risk factor for venous thromboembolism: an epidemiological evaluation J Obstet Gynaecol Can 25 2003 1011 1018
47. Gompel A., Carpentier S., Frances C., and Piette J. Risk of venous thromboembolism and oral contraceptives Lancet 359 2002 1348 1349 (Pubitemid 34310650)
48. Buyon J.P., Petri M.A., Kim M.Y., Kalunian K.C., Grossman J., and Hahn B.H. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial Ann Intern Med 142 2005 953 962
49. Mok C.C., Tang S.S., To C.H., and Petri M. Incidence and risk factors of thromboembolism in systemic lupus erythematosus: a comparison of three ethnic groups Arthritis Rheum 52 2005 2774 2782 (Pubitemid 41369106)
50. Asanuma Y., Oeser A., and Shintani A.K. Premature coronary-artery atherosclerosis in systemic lupus erythematosus N Engl J Med 349 2003 2407 2415 (Pubitemid 37542989)
51. Roman M.J., Shanker B.A., and Davis A. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus N Engl J Med 349 2003 2399 2406 (Pubitemid 37542988)
52. Svenungsson E., Jensen-Urstad K., and Heimburger M. Risk factors for cardiovascular disease in systemic lupus erythematosus Circulation 104 2001 1887 1893 (Pubitemid 32983229)
53. Hahn B.H. Systemic lupus erythematosus and accelerated atherosclerosis N Engl J Med 349 2003 2379 2380 (Pubitemid 37542984)
54. Hallegua D.S., and Wallace D.J. How accelerated atherosclerosis in SLE has changed our management of the disorder Lupus 9 2000 228 231 (Pubitemid 30199268)
55. Basdevant A., Guy-Grand B., Conard J., and Samama M. Effects of progestatin on glucido-lipid metabolism and coagulation Rev Prat 31 1981 1403 1408 (Pubitemid 11116122)
56. Cervera R., Asherson R.A., and Font J. Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature Medicine (Baltimore) 76 1997 203 212 (Pubitemid 27255823)
57. Kaslow R.A., and Masi A.T. Age, sex, and race effects on mortality from systemic lupus erythematosus in the United States Arthritis Rheum 21 1978 473 479 (Pubitemid 9126687)
58. Bermas B. Oral contraceptives in systemic lupus erythematosus - a tough pill to swallow? N Engl J Med 353 2005 2602 2604 (Pubitemid 41785899)